Risk factors for cardiovascular disease and hormone therapy in women.
作者信息
Collins P
机构信息
Department of Cardiac Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW3 6LY, UK.
出版信息
Heart. 2006 May;92 Suppl 3(Suppl 3):iii24-8. doi: 10.1136/hrt.2005.071787.
Abstract
摘要
相似文献
1
Risk factors for cardiovascular disease and hormone therapy in women.女性心血管疾病的风险因素与激素治疗
Heart. 2006 May;92 Suppl 3(Suppl 3):iii24-8. doi: 10.1136/hrt.2005.071787.
2
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).欧洲临床实践心血管疾病预防指南：执行摘要：欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第四次报告（由九个学会的代表及特邀专家组成）
Eur Heart J. 2007 Oct;28(19):2375-414. doi: 10.1093/eurheartj/ehm316. Epub 2007 Aug 28.
3
Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators.绝经后激素替代疗法能否改善糖尿病女性的血脂水平？社区动脉粥样硬化风险研究调查人员。
Diabetes Care. 1996 May;19(5):480-5. doi: 10.2337/diacare.19.5.480.
4
Cardiovascular disease risk in youth with diabetes mellitus.患有糖尿病的青少年的心血管疾病风险
Rev Endocr Metab Disord. 2006 Sep;7(3):197-204. doi: 10.1007/s11154-006-9016-y.
5
Gender and cardiovascular risk.性别与心血管风险。
J Hum Hypertens. 1996 Jun;10(6):403-7.
6
Gender differences in the cardiovascular effects of sex hormones.性激素对心血管的影响存在性别差异。
Fundam Clin Pharmacol. 2010 Dec;24(6):675-85. doi: 10.1111/j.1472-8206.2010.00817.x.
7
Blood pressure, plasma NPY and catecholamines during physical exercise in relation to menstrual cycle, ovariectomy, and estrogen replacement.
Regul Pept. 1998 Sep 25;75-76:239-45. doi: 10.1016/s0167-0115(98)00074-3.
8
[Particularities of hypertension in diabetic patient].[糖尿病患者高血压的特点]
Rev Prat. 2004 Mar 31;54(6):633-6.
9
The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women.激素替代疗法和运动对绝经后女性心血管疾病危险因素的影响。
Sports Med. 2000 Jan;29(1):39-49. doi: 10.2165/00007256-200029010-00004.
10
THYROID HORMONE REPLACEMENT REDUCES THE RISK OF CARDIOVASCULAR DISEASES IN DIABETIC NEPHROPATHY PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM.甲状腺激素替代治疗可降低伴有亚临床甲状腺功能减退的糖尿病肾病患者发生心血管疾病的风险。
Endocr Pract. 2018 Mar;24(3):265-272. doi: 10.4158/EP-2017-0017.
引用本文的文献
1
Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study.自体富血小板血浆输注对卵巢功能恢复的临床益处：一项前后对照前瞻性初步研究的证据
Medicines (Basel). 2023 Feb 27;10(3):19. doi: 10.3390/medicines10030019.
2
(Amla) Ameliorates High-Fat Diet Induced Alteration of Cardiovascular Pathophysiology.（印度醋栗）改善高脂饮食诱导的心血管病理生理学改变。
Cardiovasc Hematol Agents Med Chem. 2019;17(1):52-63. doi: 10.2174/1871525717666190409120018.
3
Smoking and drinking influence the advancing of ischemic stroke disease by targeting PTGS2 and TNFAIP3.吸烟和饮酒通过靶向PTGS2和TNFAIP3影响缺血性中风疾病的进展。
Exp Ther Med. 2018 Jul;16(1):61-66. doi: 10.3892/etm.2018.6138. Epub 2018 May 7.
本文引用的文献
1
KEEPS: The Kronos Early Estrogen Prevention Study.KEEPS：克罗诺斯早期雌激素预防研究。
Climacteric. 2005 Mar;8(1):3-12. doi: 10.1080/13697130500042417.
2
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.52个国家中与心肌梗死相关的潜在可改变风险因素的影响（INTERHEART研究）：病例对照研究
Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
3
Epidemiology of alcohol and other drug use among motor vehicle crash victims admitted to a trauma center.一家创伤中心收治的机动车碰撞事故受害者中酒精及其他药物使用情况的流行病学研究
Traffic Inj Prev. 2004 Sep;5(3):254-60. doi: 10.1080/15389580490465319.
4
Obesity, metabolic syndrome, and cardiovascular disease.肥胖、代谢综合征与心血管疾病。
J Clin Endocrinol Metab. 2004 Jun;89(6):2595-600. doi: 10.1210/jc.2004-0372.
5
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.结合马雌激素对子宫切除术后绝经后女性的影响：女性健康倡议随机对照试验
JAMA. 2004 Apr 14;291(14):1701-12. doi: 10.1001/jama.291.14.1701.
6
The prevalence of known diabetes in eight European countries.八个欧洲国家中已知糖尿病的患病率。
Eur J Public Health. 2004 Mar;14(1):10-4. doi: 10.1093/eurpub/14.1.10.
7
Evidence-based guidelines for cardiovascular disease prevention in women.女性心血管疾病预防的循证指南
Circulation. 2004 Feb 10;109(5):672-93. doi: 10.1161/01.CIR.0000114834.85476.81. Epub 2004 Feb 4.
8
Lp(a) lipoprotein--coping with heterogeneity.脂蛋白(a)——应对异质性
N Engl J Med. 2003 Nov 27;349(22):2089-90. doi: 10.1056/NEJMp038128.
9
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.特定年龄时不同胆固醇水平下冠心病的终生风险。
Arch Intern Med. 2003 Sep 8;163(16):1966-72. doi: 10.1001/archinte.163.16.1966.
10
The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention.
Curr Treat Options Cardiovasc Med. 2003 Aug;5(4):271-277. doi: 10.1007/s11936-003-0026-8.
Zotero 插件